Osmol Gap as a Surrogate Marker for Serum Propylene Glycol Concentrations in Patients Receiving Lorazepam for Sedation

Jan 21, 2006Pharmacotherapy

Osmol gap as an indicator of propylene glycol levels in patients sedated with lorazepam

AI simplified

Abstract

Osmol gap above 10 was found in 62% of high-dose lorazepam patients.

  • Serum propylene glycol concentrations were predicted by the osmol gap and the amount of propylene glycol administered.
  • Osmol gap alone showed a moderate correlation with serum propylene glycol concentrations (r(2)=0.532, p<0.05).
  • Serum lactate concentrations did not show a correlation with serum propylene glycol concentrations.
  • All high-dose patients had serum propylene glycol concentrations linked to toxicity, unlike low-dose and control patients.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free